Emma Millican, Harold Swerdlow
LGC has appointed Emma Millican as global NGS business unit manager and Harold Swerdlow as head of NGS technology development, positions the firm created to support the launch of its new NGS business unit.
Millican was previously director of scientific operations at the Wellcome Trust Sanger Institute and prior to joining the Sanger Institute, she was the UK director of forensic and applied genetics at Eurofins.
Swerdlow joins LGC from the New York Genome Center, where he was vice president of sequencing. Previously, he was head of research and development at the Wellcome Trust Sanger Institute and also served as chief technology officer at the Dolomite Center.
OncoCyte said that Mitch Levine has been appointed chief financial officer. Prior to joining OncoCyte, Levine was managing partner of Kirby Cover Capital Advisors, which provides consulting to international life sciences investment funds regarding US-based companies. In 2002 Levine founded Enable Capital Management. Prior to that, he was a founding member of The Shemano Group. He has also worked for Bear Stearns and Lehman Brothers.
Geisinger Health System has named Huntington Willard as director of the newly launched Geisinger National Precision Health Initiative, to be based near Washington, DC. Among his duties, Willard will oversee formation of a new precision health innovation lab. Willard, who was founding director of the Duke Institute for Genome Sciences & Policy and is a former president of the American Society of Human Genetics, will start in January.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.